Artificial Heart (Artificial Hearts)

Subscribe to Selected New Research on Artificial Heart

329 relevant articles (11 outcomes, 22 trials/studies) found for this Therapy

Description: A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed)

Also Known As:

Artificial Hearts; Heart, Artificial; Hearts, Artificial

Relationship Network

Therapy Context: Research Results

Equipment and Supplies

Prostheses and Implants: 9958

Artificial Heart: 329

Heart-Assist Devices: 38

Surgical Equipment: 28

Artificial Organs: 61

Artificial Heart: 329

Heart-Assist Devices: 38

Experts

1.	Copeland, Jack G: 2 articles (02/2008 - 08/2003)
2.	Reiss, N: 2 articles (01/2007 - 11/2003)
3.	Morshuis, M: 2 articles (01/2007 - 11/2003)
4.	Arusoglu, L: 2 articles (01/2007 - 11/2003)
5.	El-Banayosy, A: 2 articles (01/2007 - 11/2003)
6.	Körfer, R: 2 articles (01/2007 - 11/2003)
7.	Slepian, Marvin J: 1 article (02/2008)
8.	Umezu, Mitsuo: 1 article (01/2007)
9.	Nakatani, Takeshi: 1 article (01/2007)
10.	Sase, Kazuhiro: 1 article (01/2007)

Related Diseases

1.	Thrombosis (Thrombus) 07/01/1990 - "General design goals, including improved fit for human application, improved reliability, and elimination of thrombus formation, were identified as improvements over the clinically used Jarvik-7 artificial heart, previously developed at the Institute for Biomedical Engineering, University of Utah" 05/01/2004 - "BACKGROUND AND AIM OF THE STUDY: An in-vitro technique has been developed to assess the flow-induced thrombosis of artificial heart valves, using renneted milk as a blood analog" 01/01/1996 - "BACKGROUND AND AIM OF THE STUDY: Thrombosis remains a serious risk for patients with artificial heart valves and may be attributed in part to adverse blood flow patterns" 09/01/1975 - "These studies indicate that platelets are extremely sensitive to shear stress and raise the possibility that thrombus formation and/or accelerated platelet turnover in patients with rheumatic valvular disease or who possess artificial heart valves or other cardiac prosthetic devices could result from the effects of this physical force on circulating platelets." 11/01/2004 - "Flow stasis in an artificial heart may provide a situation where thrombus develops" Order ALL the reference details at left...
2.	Heart Failure 08/26/2004 - "The purpose was to assess the safety and efficacy of the CardioWest Total Artificial Heart in transplant-eligible patients at risk for imminent death from irreversible biventricular cardiac failure" 07/01/1989 - "The improved results of heart transplantation and the need to support hemodynamically those patients with cardiac failure while waiting for a suitable donor has heralded the development of mechanical ventricular assist pumps and the total artificial heart (TAH) as a bridge to transplantation" 05/01/2007 - "In near future, artificial heart and heart transplantation will be selected according to the conditions of the patients with profound heart failure." 05/01/2007 - "Artificial heart or heart transplantation are required for the treatment of profound heart failure" 01/01/2007 - "The working group for assessment guidelines of next-generation artificial hearts reviewed the trend in the prevalence of heart failure and examined the potential usefulness of such devices in Japan and in other countries as a fundamental part of the process of establishing appropriate guidelines" Order ALL the reference details at left...
3.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/1997 - "The products of modern technology including computerized tomography, computer enhanced digital angiography, magnetic resonance imaging, ultrasonic-cardiography, positron emission tomography, single photon emission computerized tomography, percutaneous transluminal coronary angioplasty and other techniques, laser, artificial pacemaker, artificial heart etc. have greatly improved the capacity of diagnosis and therapy of cardiovascular diseases" 11/01/1985 - "Past estimates of the potential usage of artificial hearts have been reviewed in the context of advances in medical care and in the prevention of cardiovascular disease" 01/01/1988 - "The objectives of these studies were to reduce thromboembolic complications in arterial cardiovascular diseases (prevention of myocardial infarction in unstable angina, secondary prevention of acute myocardial infarction, and increased patency of aortocoronary bypass grafts) and to reduce platelet deposition on artificial surfaces (artificial heart valves and hemodialysis shunts)" Order ALL the reference details at left...
4.	Heart Diseases (Heart Disease) 07/01/2000 - "Development of the artificial heart continues to offer some relief for patients with end-stage heart disease." 01/01/2007 - "Every patient after heart valve replacement in Silesian Center of Heart Disease in Zabrze obtains Identity Card of the Patient with Artificial Heart Valve" 01/01/2006 - "End-stage heart disease, high-risk research, and competence to consent: the case of the AbioCor artificial heart." 10/01/2003 - "This report discusses the keynote lectures (Prophylactic Effects of Statins on Ischaemic Heart Disease, Diet and Wine as Cardioprotection, Artificial Heart Technology and Therapeutics) and the symposia presented at the meeting" 02/08/2002 - "The highly public reintroduction of the total artificial heart last year has prompted renewed interest in mechanical circulatory support systems for the treatment of end-stage heart disease." Order ALL the reference details at left...
5.	Critical Illness (Critically Ill) 07/01/1986 - "While certain critically ill patients who are awaiting cardiac transplantation can be stabilized with either drugs, the intraaortic balloon pump, or a left ventricular assist device, other patients do not respond to these therapies and the use of a safe and effective artificial heart can be lifesaving" 11/01/2000 - "Development of a scaled down total artificial heart system expands this type of circulatory support to those critically ill patients previously deemed poor candidates because of their smaller body habitus." 08/01/1999 - "CONCLUSIONS: The CardioWest Total Artificial Heart salvaged 20 of 24 critically ill patients" 01/01/1998 - "Given the success of cardiac transplantation, the artificial heart was relegated to temporary use in critically ill patients who were waiting for a donor heart" 10/01/1987 - "These projects range from artificial hearts to diagnostic/therapeutic cardiac catheters which are saving the lives of many critically ill patients." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Aspirin (Acetylsalicylic Acid)
2.	Warfarin (Coumadin)
3.	Anticoagulants
4.	clopidogrel (Plavix)
5.	Dipyridamole (Persantine)
6.	Platelet Aggregation Inhibitors (Antiplatelet Drugs)
7.	Plasticizers
8.	erucylphosphocholine
9.	Polyurethanes (Polyurethane)
10.	Heparin (Liquaemin)

Related Therapies and Procedures

1.	Heart Transplantation (Grafting, Heart)
2.	Transplantation (Transplant Recipients)
3.	Transplants (Transplant)
4.	Prostheses and Implants (Prosthesis)
5.	Lasers (Laser)

Best Treatments:
Research Summary Report
on Thrombosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1253 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>